Cord-Blood Transplantation in Patients with Minimal Residual Disease - Wikidata - wikimedia - TriplyDB

Cord-Blood Transplantation in Patients with Minimal Residual Disease

Cord-Blood Transplantation in Patients with Minimal Residual Disease

http://www.wikidata.org/entity/Q33911314

about

Alternative Donor Graft Sources for Adults with Hematologic Malignancies: A Donor for All Patients in 2017!Umbilical Cord Blood Transplantation: Challenges and Future Directions.Toward a Rapid Production of Multivirus-Specific T Cells Targeting BKV, Adenovirus, CMV, and EBV from Umbilical Cord Blood.From patient centered risk factors to comprehensive prognostic models: a suggested framework for outcome prediction in umbilical cord blood transplantation.Engineering cord blood to improve engraftment after cord blood transplant.Single- or double-unit UCBT following RIC in adults with AL: a report from Eurocord, the ALWP and the CTIWP of the EBMT Haploidentical allograft is superior to matched sibling donor allograft in eradicating pre-transplantation minimal residual disease of AML patients as determined by multiparameter flow cytometry: a retrospective and prospective analysis.Intestinal Microbiota and Relapse After Hematopoietic-Cell Transplantation.Clinical impact of NK-cell reconstitution after reduced intensity conditioned unrelated cord blood transplantation in patients with acute myeloid leukemia: analysis of a prospective phase II multicenter trial on behalf of the Société Française de Gr Allogeneic Hematopoietic Stem Cell Transplantation with Myeloablative Conditioning Is Associated with Favorable Outcomes in Mixed Phenotype Acute Leukemia.Immune reconstitution and outcomes after conditioning with anti-thymocyte-globulin in unrelated cord blood transplantation; the good, the bad, and the ugly.Advances in umbilical cord blood cell therapy: the present and the future.Optimal Practices in Unrelated Donor Cord Blood Transplantation for Hematologic Malignancies.Alloreactivity: the Janus-face of hematopoietic stem cell transplantation.Who Should Receive a Transplant for Acute Lymphoblastic Leukaemia?Clinical Studies in Hematologic Microtransplantation.Graft predominance after double umbilical cord blood transplantation: a review.Maternal microchimerism is prevalent in cord blood in memory T cells and other cell subsets, and persists post-transplant.Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation.The Prognostic Significance of Measurable ("Minimal") Residual Disease in Acute Myeloid Leukemia.Occurrence of graft-versus-host disease increases mortality after umbilical cord blood transplantation for acute myeloid leukaemia: a report from Eurocord and the ALWP of the EBMT.Erythropoietin in umbilical cord blood transplantation: defining the role and implications.Going home for the holidays? Take a shortcut!Importance of conditioning regimen intensity, MRD positivity, and KIR ligand mismatch in UCB transplantation.Antagonism of PPAR-γ signaling expands human hematopoietic stem and progenitor cells by enhancing glycolysis.Effects of pre- and post-transplantation minimal residual disease on outcomes in pediatric patients with acute myeloid leukemia receiving human leukocyte antigen-matched or mismatched related donor allografts.Cord blood-derived T cells allow the generation of a more naïve tumor-reactive cytotoxic T-cell phenotype.Is it time to re-think a sustainable banking model for the Italian Cord Blood Network?Factors Associated with Long-Term Risk of Relapse after Unrelated Cord Blood Transplantation in Children with Acute Lymphoblastic Leukemia in Remission.Better outcomes of modified myeloablative conditioning without antithymocyte globulin versus myeloablative conditioning in cord blood transplantation for hematological malignancies: A retrospective (development) and a prospective (validation) study.One or two umbilical cord blood cell units? Caveat emptor.Against the odds: haplo-cord grafts protect from GvHD and relapse.Haplo-Cord transplantation compared to haploidentical transplantation with post-transplant cyclophosphamide in patients with AML.Clinical T Cell Receptor Repertoire Deep Sequencing and Analysis: An Application to Monitor Immune Reconstitution Following Cord Blood Transplantation

P2860

Q30252339-B266C114-D91E-4241-AB67-E5EBF57B2BC4 Q30352323-A4A799EC-8A0A-4FBF-83E8-1840D10E6289 Q33633262-C66AEB0D-DF57-42BD-BA0F-57B51A6442E6 Q33766984-10DE40C6-4430-4613-B2CD-9E00360DD3EB Q33766995-4F30E16B-5E70-4BAA-933A-B627018A8D41 Q33820379-D17FD6B6-CCF5-4E56-9464-EC16C8B7C3F0 Q33868700-0B796FCA-24F8-48C9-9822-96488FAB92C5 Q36308832-A5C1E381-0A17-4A22-A177-E8C92FF05214 Q38666661-FC843F45-3A2B-4155-9CE8-D1923DEFDA6E Q38685482-4FA340E9-D592-4866-8BAE-9FE8BCDE2BF9 Q38728525-3D80FD5C-D292-4CB1-AC39-3952968AF749 Q38734758-2138521F-E17F-41C0-926D-7EE909BCE1DD Q38747929-E14ECBA9-8979-4D1E-AD4F-6AF9050CE60B Q38922235-C3B5E640-E51A-4058-B87D-E9CCA5AA1EAF Q38953608-DC45A4B5-9850-4EC0-97CD-5F108EFFD107 Q39147431-55DE5EC9-D25C-45E8-9953-78A61F70D157 Q39368481-6B25C837-BB5F-4746-AFE3-33363CCB338D Q40162729-03B3D89A-FBAB-4A73-95C6-5FFCCD24DF92 Q47570389-F48A69C0-55DF-4A39-A38D-5DC36E2421C2 Q47804815-718694A1-9F8E-4DA9-87C5-5E8520906820 Q47865655-BB9C40C3-9220-475F-B761-F0DF73859649 Q47970956-D2EB08E6-443C-4B82-AF43-90B3ABA59BC6 Q48324190-03E29A3F-961E-478C-B4DD-C4FE1AA6FE9F Q49391438-19881A04-4592-42BF-8FF0-C408EC20EFF1 Q49612432-23F39C9E-F70A-4462-99FF-D033DB412FE7 Q50000844-77C85497-7206-49F3-B22E-2FE7008A37E6 Q50098673-EA41664E-078C-418C-8F7C-B3BE75130DC9 Q50659098-5C697957-901D-4348-899A-D6BCA282D8A7 Q50704219-946F3AF2-1DF8-4AA4-8AD4-98D38148A8F9 Q52688938-E969C466-6C31-4EB9-AEF6-84304950A2E4 Q52804927-8D58D0EE-1D29-4F55-B420-8D56BBAFF976 Q53211922-83712689-9BC3-4FD9-AADB-8A67E835D9A1 Q54718917-6F3C4402-DEB7-4430-96FF-E095E5643E64 Q59129883-4CD586E9-AB01-4092-B634-9178E80EB693

P2860

Cord-Blood Transplantation in Patients with Minimal Residual Disease

http://www.wikidata.org/entity/Q33911314

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@ast

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@en

type

label

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@ast

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@en

prefLabel

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@ast

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@en

P1433

Q33911314-A12BD2D0-04E0-4DE2-B2DC-DF53AD9B5718

P1476

Q33911314-E75870D7-F2CA-4423-BE18-4C175E282C63

P2093

Q33911314-17C1D6AF-72F3-46CC-B2D3-E48E8BA7979A

Q33911314-28ED4F84-F62C-41AF-812B-98ACA6F2839D

Q33911314-5BD23EB1-1626-4390-B6F8-69C281B4A11D

Q33911314-75117678-AE88-4118-ADF6-A655B52FA8AD

Q33911314-864A51A4-A9A8-400E-9254-DEC3250F0044

Q33911314-B33C532B-C52E-455D-8C97-4D1FF11E8A8C

Q33911314-C74B8CCC-0107-4393-8733-2833AFDF90DF

Q33911314-CA89FF30-F0B4-407F-8270-FD1832AB959C

Q33911314-D2A03F2E-36F3-4744-B46D-9F5B376FAA5C

Q33911314-D394B41F-EC54-4968-AED3-7DB5B27880E3

P2860

Q33911314-174BFAEB-F4A8-4767-B9FB-FB5E15B64062

Q33911314-1D32B7BA-B92E-41D4-B160-1456842A71E4

Q33911314-3D5C13DE-8C27-46C7-B955-8D0DDCB3BD8E

Q33911314-3D7B91E2-6815-433E-9956-1428FC18163C

Q33911314-4BBED25B-B073-486B-AEE0-37902ED5DD0C

Q33911314-562C3F2B-3CD2-4C10-ACB5-9A785B678F1D

Q33911314-5A43E0A4-AFBA-4549-8CAA-6C59651421E0

Q33911314-5FD97BAD-63F5-4674-B892-EB71F24F9E96

Q33911314-7791D722-1792-4949-8B3C-9E9B8F9A955A

Q33911314-7797A449-481B-4C78-9E8D-CDE860105C40

P304

Q33911314-362D7217-0213-42C1-89B7-BB2C4CCBF20D

P31

Q33911314-D2DD251F-FE0C-4AA8-8060-C54E146CF086

P356

Q33911314-BB4E2C3A-A93E-4911-A565-02DBE4984CF4

P407

Q33911314-023C0FFB-8B1A-404D-9132-5A7A808B3162

P433

Q33911314-010358CF-4539-4E1B-88FE-090C52ED0F08

P478

Q33911314-DC4AC8B1-CBAC-4AEC-9772-8BDA67D15412

P50

Q33911314-2960F63F-BB3B-4D1C-A484-7527DC612BF8

Q33911314-C8BAF2DB-5DF0-4763-9BE2-48026273060A

Q33911314-CFD9F1E9-A532-46E9-AF58-CEA7D0527512

P577

Q33911314-AD6D5043-2273-4622-9BF8-90A0986F784D

P698

Q33911314-43AE1970-4785-4076-9619-2C4357ED08D5

P932

Q33911314-DC15819E-FE96-4324-9EC3-7A7994E3CFD0

P356

P1433

The New England Journal of Medicine

P1476

Cord-Blood Transplantation in Patients with Minimal Residual Disease

@en

P2093

Ann Dahlberg

http://www.w3.org/2001/XMLSchema#string

Ann Woolfrey

http://www.w3.org/2001/XMLSchema#string

Brent Wood

http://www.w3.org/2001/XMLSchema#string

Colleen Delaney

http://www.w3.org/2001/XMLSchema#string

Effie Petersdorf

http://www.w3.org/2001/XMLSchema#string

Filippo Milano

http://www.w3.org/2001/XMLSchema#string

Joachim H Deeg

http://www.w3.org/2001/XMLSchema#string

Kristine Doney

http://www.w3.org/2001/XMLSchema#string

Mary E Flowers

http://www.w3.org/2001/XMLSchema#string

Mohamed Sorror

http://www.w3.org/2001/XMLSchema#string

P2860

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators.

Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution.

Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation.

Hematopoietic engraftment and survival in adult recipients of umbilical-cord blood from unrelated donors.

Allogeneic hematopoietic cell transplantation for hematologic malignancy: relative risks and benefits of double umbilical cord blood

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Unrelated cord blood transplantation in adult and pediatric acute lymphoblastic leukemia: effect of minimal residual disease on relapse and survival

Adjusted estimates for time-to-event endpoints

Significance of minimal residual disease before myeloablative allogeneic hematopoietic cell transplantation for AML in first and second complete remission.

Cord-blood engraftment with ex vivo mesenchymal-cell coculture.

P304

944-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1602074

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

375

http://www.w3.org/2001/XMLSchema#string

P50

Brenda M Sandmaier

Frederick R. Appelbaum

Marco Mielcarek

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27602666

http://www.w3.org/2001/XMLSchema#string

P932

5513721

http://www.w3.org/2001/XMLSchema#string